Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes. - Wikidata - wikimedia - TriplyDB

Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

http://www.wikidata.org/entity/Q33706144

about

Endometriosis: where are we and where are we going?BMPR1B up-regulation via a miRNA binding site variation defines endometriosis susceptibility and CA125 levels Endometriosis and ovarian cancer: a systematic review.Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis.Plasma glutamate-modulated interaction of A2AR and mGluR5 on BMDCs aggravates traumatic brain injury-induced acute lung injury Relationship between endometriosis and cancer from current perspective.Clinicopathological characteristics of ovarian carcinomas associated with endometriosis.A polymorphism at miRNA-122-binding site in the IL-1α 3'UTR is associated with risk of epithelial ovarian cancer.

P2860

Q26750772-1F65B239-DC5D-4F5F-87EB-90D37A5F6CAA Q35067319-C3809C1C-E775-45C6-A76C-5767A8EC2694 Q35116887-C26611CC-D65C-4E94-811A-793E61539FCE Q36263144-FF056D7C-CC8D-4D00-A915-C86BA5E87F6F Q36750067-5D8D330A-7EEB-4B6E-84A2-611664D0FFCB Q37916323-8C6AEDF8-93BE-49CE-9948-107A56F04DA9 Q45028382-661A35E7-61C1-449C-AA02-96B1D5A05F2A Q54192639-03E39EA7-B902-4AB7-B30F-9D6D1E0E748A

P2860

Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

http://www.wikidata.org/entity/Q33706144

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Expression of interleukin-1 (I ...... iated ovarian cancer subtypes.

@ast

Expression of interleukin-1 (I ...... iated ovarian cancer subtypes.

@en

type

label

Expression of interleukin-1 (I ...... iated ovarian cancer subtypes.

@ast

Expression of interleukin-1 (I ...... iated ovarian cancer subtypes.

@en

prefLabel

Expression of interleukin-1 (I ...... iated ovarian cancer subtypes.

@ast

Expression of interleukin-1 (I ...... iated ovarian cancer subtypes.

@en

P1433

Q33706144-6396D41B-E837-4146-B146-B3E5E70DAC7F

P1476

Q33706144-1B793FF6-AF97-4153-BA21-91811619AD37

P2093

Q33706144-3D0B63B7-D688-457B-A4BA-5A723FA9669A

Q33706144-96C42A71-156C-4F9E-A2F9-B8F263FF5304

Q33706144-E1594FC0-DF8A-43F5-8048-59C5E0CEF5E5

Q33706144-EE5E7ADE-625B-442F-BD7A-3FB8C265FF2A

Q33706144-FAD7D29E-AB6C-40C6-BB37-830FC7A56097

P2860

Q33706144-03CA3BCC-5DB7-4C28-BF6E-BCDF3C3C7A33

Q33706144-0E427378-A2E4-449C-A44B-1536D8168EDB

Q33706144-16868ED8-3ECB-4131-B96E-C00CA7BC7ED1

Q33706144-1D49DDB4-B589-47FB-87F8-4ADDB2F40A9C

Q33706144-249C0748-7FEB-44EC-8AFD-BD9CE8B39868

Q33706144-39E8A1B7-48A2-4D93-8FE1-AA48A8D2DB77

Q33706144-4178C700-B219-42A9-96FB-3D55B57FBC79

Q33706144-44D18C80-BBF2-4928-BB19-15474DBFA416

Q33706144-49C8CF2D-3B42-450E-B926-980809A45DFC

Q33706144-57AE47A3-2D53-4964-AB84-085D643F9219

P2888

Q33706144-15A0992C-3F4B-4BEB-9A60-13E891E6864C

P304

Q33706144-3A3400C2-E3DF-4512-B347-5590A07B79BA

P31

Q33706144-8B10F005-9824-463A-8196-75027F5753DD

P356

Q33706144-496BE258-3CCF-4CFC-B4F6-5C1E07268270

P478

Q33706144-2BD629EE-2465-46C2-9E9A-1E1D0B277B2E

P577

Q33706144-3E1F14AF-CACE-42B7-87CB-5C81340EFF40

P5875

Q33706144-4048B7A0-F97B-4473-B48D-A0B62BCE919F

P6179

Q33706144-61AAC1F2-B544-4AB0-AEF0-D7ABA392E63E

P698

Q33706144-5CFF8DEB-7A90-400F-ADDF-B424EA11B0E5

P921

Q33706144-42E98087-D4B3-43E9-8236-E2C53D51CF39

P932

Q33706144-33E1B2E4-A823-40AD-9E74-C4D735DE2926

P356

P1433

Journal of Ovarian Research

P1476

Expression of interleukin-1 (I ...... iated ovarian cancer subtypes.

@en

P2093

Aziz Aris

http://www.w3.org/2001/XMLSchema#string

Mamadou Keita

http://www.w3.org/2001/XMLSchema#string

Manuella Pelmus

http://www.w3.org/2001/XMLSchema#string

Paul Bessette

http://www.w3.org/2001/XMLSchema#string

Youssef Ainmelk

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction

Inflammation and cancer

Interleukin-1 receptor antagonist: role in biology

Tumour-educated macrophages promote tumour progression and metastasis

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness.

The morphogenic/cytotoxic and prostaglandin-stimulating activities of interleukin-1 beta in the rat ovary are nitric oxide independent

P2888

P304

3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1757-2215-3-3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41561342

http://www.w3.org/2001/XMLSchema#string

P6179

1042442115

http://www.w3.org/2001/XMLSchema#string

P698

20181040

http://www.w3.org/2001/XMLSchema#string

P921

P932

2832771

http://www.w3.org/2001/XMLSchema#string